Navigation Links
Icagen Board Beginning to Follow Xmark Direction

RIDGEFIELD, Conn., Feb. 2 /PRNewswire/ -- Xmark Opportunity Partners, LLC ("Xmark"), the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., has, in the past, sent letters to the Board of Directors of Icagen, Inc. (Nasdaq: ICGN) setting forth its dissatisfaction with the company's corporate governance, management and strategic direction. Xmark would like to take this opportunity to respond to the Form 8-K filed by the company on January 29, 2009.

While Xmark applauds the Compensation Committee of the Board of Directors for choosing to not pay cash bonuses to the company's executive officers for 2008, it believes that this is but a small step in the right direction. Xmark is pleased that cash bonuses for the company's executive officers for 2009 will be based, in part, on "building shareholder confidence." However, Xmark believes that there are additional steps that can be taken by the company to pare its cash-burn requirements. As Xmark has repeatedly pointed out to the company, these are challenging economic times; the Board of Directors should continue to tighten the company's economic belt for the coming years.

Xmark remains committed to monitoring its significant common stock investment in the company and remains hopeful that it can engage in productive dialogue with the company to help it maximize shareholder value by, among other things, pursuing strategic alternatives.

SOURCE Xmark Opportunity Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Xmark Sends Letters to Icagens Board of Directors: Questions Companys Leadership as Well as Motives Behind Adoption of Poison Pill
2. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
3. MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members
4. Elite Meetings International Names New Advisory Board
5. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
6. Shaklee Partners With U.S. Ski Team and U.S. Snowboarding in Preparation for the 2010 Games in Vancouver
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 9, 2009
8. Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board
9. Quest Diagnostics Board Authorizes $500 Million in Share Repurchases
10. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
11. PPGI Appoints Rick Strandlund to the Board of Directors
Post Your Comments:
(Date:11/25/2015)... ... , ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David ... 130884WC. , According to court documents, Adcock testified that on May 10, 2010 he ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Beddit® has launched ... Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that rates ... how well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development and ... of its current state of the art research, development and manufacturing facility outside ... its manufacturing capacity as well as to support its clients’ growing research and ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... -- --> --> ... das Patent über eine neue Hepatitis-B-Behandlung, welches sie gemeinsam ... Enyo Pharma vergeben haben. Im Rahmen ... von Edelris gemeinsam mit seinen Partnern Inserm und Poxel ... identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die zu ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
Breaking Medicine Technology: